HBV Forum 6 was held in Boston, MA on November 7th, 2019.
Agenda
Participants
Presentations
Welcoming Remarks
Jessica Weber, The Forum for Collaborative Research
Session I: Field Updates
What's Hot at The Liver Meeting?
Edward Gane, University of Auckland
FDA Draft Guidance: Chronic Hepatitis D Virus Infection
Aimee Hodowanec, U.S. Food & Drug Administration
Hepatitis B Study Update
Scott Harris, Altimmune, Inc.
Session II: Regulatory Consideration Panel Topics
Panel 3: Core Inhibitor Sub-Classes and Mechanisms of Action
Oliver Lenz, Janssen
Session III: HBV Forum Updates
Immune Monitoring Working Group
Adam Gehring, Toronto Centre for Liver Disease
Liver Safety Monitoring Manuscript (JVH)
Robert Fontana, University of Michigan
HBsAg Loss Meta-Analysis
Hannah Choi, Toronto Centre for Liver Disease
Planned Collaboration: Stop Nuc Studies
Jordan Feld, University Health Network
Session V: Field Updates and Special Debate
ICE-HBV: Global Fund & Messaging Briefing
Massimo Levrero, ICE-HBV Board
Special Debate: The Case for Test and Treat All HBV Patients
Homie Razavi, Center for Disease Analysis Foundation
Special Debate: Just Say No to Test and Treat for HBV
Brian McMahon, Alaska Native Tribal Health Consortium